doi: 10.1373/clinchem.2009.125377.
Epub 2009 Jun 18.
Understanding resistance to tamoxifen in hormone receptor-positive breast cancer
Affiliations
- PMID: 19541862
- DOI: 10.1373/clinchem.2009.125377
Item in Clipboard
Understanding resistance to tamoxifen in hormone receptor-positive breast cancer
Clin Chem.
2009 Aug.
No abstract available
Similar articles
-
Modification of tamoxifen response: what have we learned?J Clin Oncol. 2008 Apr 1;26(10):1764-5; author reply 1765-6. doi: 10.1200/JCO.2007.15.5432. J Clin Oncol. 2008. PMID: 18375910 No abstract available.
-
Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.Clin Adv Hematol Oncol. 2008 Nov;6(11):825-33. Clin Adv Hematol Oncol. 2008. PMID: 19194367
-
Update on CYP2D6 and its impact on tamoxifen therapy.Clin Adv Hematol Oncol. 2010 Aug;8(8):536-8. Clin Adv Hematol Oncol. 2010. PMID: 20966889 No abstract available.
-
Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?Expert Rev Anticancer Ther. 2011 Feb;11(2):185-93. doi: 10.1586/era.10.228. Expert Rev Anticancer Ther. 2011. PMID: 21342038 Review.
-
PharmGKB summary: tamoxifen pathway, pharmacokinetics.Pharmacogenet Genomics. 2013 Nov;23(11):643-7. doi: 10.1097/FPC.0b013e3283656bc1. Pharmacogenet Genomics. 2013. PMID: 23962908 Free PMC article. Review. No abstract available.
Cited by
-
The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen.Clin Exp Med. 2017 Aug;17(3):383-393. doi: 10.1007/s10238-016-0428-z. Epub 2016 May 25. Clin Exp Med. 2017. PMID: 27225751
-
DCTPP1 Expression as a Predictor of Chemotherapy Response in Luminal A Breast Cancer Patients.Biomedicines. 2024 Aug 2;12(8):1732. doi: 10.3390/biomedicines12081732. Biomedicines. 2024. PMID: 39200195 Free PMC article.
-
Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA-200 and the downregulation of PI3K-Akt signaling pathway.Oncol Lett. 2017 Sep;14(3):3741-3747. doi: 10.3892/ol.2017.6580. Epub 2017 Jul 15. Oncol Lett. 2017. PMID: 28927141 Free PMC article.
-
Identifying prognostic subgroups of luminal-A breast cancer using deep autoencoders and gene expressions.PLoS Comput Biol. 2023 May 30;19(5):e1011197. doi: 10.1371/journal.pcbi.1011197. eCollection 2023 May. PLoS Comput Biol. 2023. PMID: 37253056 Free PMC article.
-
Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses.NPJ Breast Cancer. 2019 Aug 2;5:21. doi: 10.1038/s41523-019-0116-8. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 31396557 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
